Szigetvari, N. M., Dhawan, D., Ramos-Vara, J. A., Leamon, C. P., Klein, P. J., Ruple, A. A., . . . Knapp, D. W. (2018). Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinoma. Oncotarget.
Citação norma ChicagoSzigetvari, Nicholas M., et al. "Phase I/II Clinical Trial of the Targeted Chemotherapeutic Drug, Folate-tubulysin, in Dogs With Naturally-occurring Invasive Urothelial Carcinoma." Oncotarget 2018.
ציטוט MLASzigetvari, Nicholas M., et al. "Phase I/II Clinical Trial of the Targeted Chemotherapeutic Drug, Folate-tubulysin, in Dogs With Naturally-occurring Invasive Urothelial Carcinoma." Oncotarget 2018.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.